• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在单个细胞的膜微域内分析占据拮抗剂的腺苷 A3 受体的动力学,为受体二聚化和变构提供了证据。

Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism.

机构信息

Institute of Cell Signalling, School of Life Sciences, Medical School, and.

School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, Nottingham, UK.

出版信息

FASEB J. 2014 Oct;28(10):4211-22. doi: 10.1096/fj.13-247270. Epub 2014 Jun 26.

DOI:10.1096/fj.13-247270
PMID:24970394
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4202110/
Abstract

In our previous work, using a fluorescent adenosine-A3 receptor (A3AR) agonist and fluorescence correlation spectroscopy (FCS), we demonstrated high-affinity labeling of the active receptor (R*) conformation. In the current study, we used a fluorescent A3AR antagonist (CA200645) to study the binding characteristics of antagonist-occupied inactive receptor (R) conformations in membrane microdomains of individual cells. FCS analysis of CA200645-occupied A3ARs revealed 2 species, τD2 and τD3, that diffused at 2.29 ± 0.35 and 0.09 ± 0.03 μm(2)/s, respectively. FCS analysis of a green fluorescent protein (GFP)-tagged A3AR exhibited a single diffusing species (0.105 μm(2)/s). The binding of CA200645 to τD3 was antagonized by nanomolar concentrations of the A3 antagonist MRS 1220, but not by the agonist NECA (up to 300 nM), consistent with labeling of R. CA200645 normally dissociated slowly from the A3AR, but inclusion of xanthine amine congener (XAC) or VUF 5455 during washout markedly accelerated the reduction in the number of particles exhibiting τD3 characteristics. It is notable that this effect was accompanied by a significant increase in the number of particles with τD2 diffusion. These data show that FCS analysis of ligand-occupied receptors provides a unique means of monitoring ligand A3AR residence times that are significantly reduced as a consequence of allosteric interaction across the dimer interface

摘要

在我们之前的工作中,使用荧光腺苷-A3 受体 (A3AR) 激动剂和荧光相关光谱 (FCS),我们证明了高亲和力标记活性受体 (R*)构象。在当前的研究中,我们使用荧光 A3AR 拮抗剂 (CA200645) 来研究配体占据的失活受体 (R)构象在单个细胞的膜微域中的结合特性。CA200645 占据的 A3AR 的 FCS 分析显示出 2 种扩散,τD2 和 τD3,分别以 2.29 ± 0.35 和 0.09 ± 0.03 μm(2)/s 的速度扩散。绿色荧光蛋白 (GFP) 标记的 A3AR 的 FCS 分析显示出单一的扩散物种 (0.105 μm(2)/s)。CA200645 与 τD3 的结合被 A3 拮抗剂 MRS 1220 的纳摩尔浓度拮抗,但不受激动剂 NECA 的影响(高达 300 nM),与 R 的标记一致。CA200645 通常从 A3AR 缓慢解离,但在冲洗过程中包含黄嘌呤胺同系物 (XAC) 或 VUF 5455 时,显著加速了显示 τD3 特征的粒子数量的减少。值得注意的是,这种效应伴随着 τD2 扩散的粒子数量的显著增加。这些数据表明,配体占据的受体的 FCS 分析提供了一种独特的监测配体 A3AR 停留时间的方法,由于二聚体界面的变构相互作用,停留时间显著缩短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/eacf6f1e2ceb/z380101499120009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/e7fcaf55be53/z380101499120001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/14572152403b/z380101499120002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/78f3550b03d6/z380101499120003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/faab29d26a94/z380101499120004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/cb8ef804e4f7/z380101499120005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/8643942c9fd1/z380101499120006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/f8939216a329/z380101499120007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/7dc3d57c8468/z380101499120008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/eacf6f1e2ceb/z380101499120009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/e7fcaf55be53/z380101499120001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/14572152403b/z380101499120002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/78f3550b03d6/z380101499120003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/faab29d26a94/z380101499120004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/cb8ef804e4f7/z380101499120005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/8643942c9fd1/z380101499120006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/f8939216a329/z380101499120007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/7dc3d57c8468/z380101499120008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b29/4202110/eacf6f1e2ceb/z380101499120009.jpg

相似文献

1
Kinetic analysis of antagonist-occupied adenosine-A3 receptors within membrane microdomains of individual cells provides evidence of receptor dimerization and allosterism.在单个细胞的膜微域内分析占据拮抗剂的腺苷 A3 受体的动力学,为受体二聚化和变构提供了证据。
FASEB J. 2014 Oct;28(10):4211-22. doi: 10.1096/fj.13-247270. Epub 2014 Jun 26.
2
Agonist-occupied A3 adenosine receptors exist within heterogeneous complexes in membrane microdomains of individual living cells.激动剂占据的A3腺苷受体存在于单个活细胞膜微区的异质复合物中。
FASEB J. 2008 Mar;22(3):850-60. doi: 10.1096/fj.07-8180com. Epub 2007 Oct 24.
3
Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics.同源型腺苷 A3 受体变构相互作用:利用单细胞配体结合动力学进行定量分析。
FASEB J. 2011 Oct;25(10):3465-76. doi: 10.1096/fj.11-186296. Epub 2011 Jun 29.
4
Antagonist selective modulation of adenosine A1 and A3 receptor pharmacology by the food dye Brilliant Black BN: evidence for allosteric interactions.食用色素亮黑 BN 对腺苷 A1 和 A3 受体药理学的拮抗剂选择性调节:变构相互作用的证据。
Mol Pharmacol. 2010 Apr;77(4):678-86. doi: 10.1124/mol.109.063065. Epub 2010 Jan 19.
5
A live cell NanoBRET binding assay allows the study of ligand-binding kinetics to the adenosine A receptor.活细胞 NanoBRET 结合测定法可用于研究配体与腺苷 A 受体的结合动力学。
Purinergic Signal. 2019 Jun;15(2):139-153. doi: 10.1007/s11302-019-09650-9. Epub 2019 Mar 27.
6
Pharmacological characterization of DPTN and other selective A adenosine receptor antagonists.DPTN 及其他选择性 A 腺苷受体拮抗剂的药理学特性。
Purinergic Signal. 2021 Dec;17(4):737-746. doi: 10.1007/s11302-021-09823-5. Epub 2021 Oct 28.
7
Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells.单个活细胞中A1-腺苷受体-拮抗剂复合物形成与扩散的定量分析
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4673-8. doi: 10.1073/pnas.0400420101. Epub 2004 Mar 16.
8
Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.咪唑喹啉变构增强剂LUF6000对人A3腺苷受体激动剂效力的灵活调节
BMC Pharmacol. 2008 Dec 12;8:20. doi: 10.1186/1471-2210-8-20.
9
Efficient G protein coupling is not required for agonist-mediated internalization and membrane reorganization of the adenosine A receptor.激动剂介导的腺苷 A 受体内化和膜重排并不需要 G 蛋白偶联的高效性。
FASEB J. 2021 Apr;35(4):e21211. doi: 10.1096/fj.202001729RR.
10
A Non-imaging High Throughput Approach to Chemical Library Screening at the Unmodified Adenosine-A Receptor in Living Cells.一种用于在活细胞中未修饰的腺苷 A 受体上进行化学文库筛选的非成像高通量方法。
Front Pharmacol. 2017 Dec 13;8:908. doi: 10.3389/fphar.2017.00908. eCollection 2017.

引用本文的文献

1
Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H Receptor.基于肽键的荧光配体对组胺 H 受体的优化。
J Med Chem. 2022 Jun 23;65(12):8258-8288. doi: 10.1021/acs.jmedchem.2c00125. Epub 2022 Jun 3.
2
Regionally selective cardiovascular responses to adenosine A and A receptor activation.腺苷 A 受体激活的区域性选择性心血管反应。
FASEB J. 2022 Apr;36(4):e22214. doi: 10.1096/fj.202101945R.
3
Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.

本文引用的文献

1
Observed drug-receptor association rates are governed by membrane affinity: the importance of establishing "micro-pharmacokinetic/pharmacodynamic relationships" at the β2-adrenoceptor.观察到的药物-受体结合率受膜亲和力控制:在β2-肾上腺素受体建立“微药代动力学/药效学关系”的重要性。
Mol Pharmacol. 2014 Apr;85(4):608-17. doi: 10.1124/mol.113.090209. Epub 2014 Jan 29.
2
The role of a sodium ion binding site in the allosteric modulation of the A(2A) adenosine G protein-coupled receptor.钠离子结合位点在 A(2A)腺苷 G 蛋白偶联受体变构调节中的作用。
Structure. 2013 Dec 3;21(12):2175-85. doi: 10.1016/j.str.2013.09.020. Epub 2013 Nov 7.
3
肠降血糖素肽 Exendin-4 的酰化直接影响胰高血糖素样肽-1 受体信号转导和转运。
Mol Pharmacol. 2021 Oct;100(4):319-334. doi: 10.1124/molpharm.121.000270. Epub 2021 Jul 27.
4
Efficient G protein coupling is not required for agonist-mediated internalization and membrane reorganization of the adenosine A receptor.激动剂介导的腺苷 A 受体内化和膜重排并不需要 G 蛋白偶联的高效性。
FASEB J. 2021 Apr;35(4):e21211. doi: 10.1096/fj.202001729RR.
5
Chemical Probes for the Adenosine Receptors.腺苷受体的化学探针
Pharmaceuticals (Basel). 2019 Nov 12;12(4):168. doi: 10.3390/ph12040168.
6
Probe dependence of allosteric enhancers on the binding affinity of adenosine A -receptor agonists at rat and human A -receptors measured using NanoBRET.使用 NanoBRET 测量大鼠和人 A 受体上腺苷 A -受体激动剂的结合亲和力,研究变构增强剂对探针的依赖性。
Br J Pharmacol. 2019 Apr;176(7):864-878. doi: 10.1111/bph.14575. Epub 2019 Mar 6.
7
Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling.蛋白质-配体(非)结合动力学作为实验与建模交叉领域药物发现的新范式。
Medchemcomm. 2017 Jan 30;8(3):534-550. doi: 10.1039/c6md00581k. eCollection 2017 Mar 1.
8
Development of novel fluorescent histamine H-receptor antagonists to study ligand-binding kinetics in living cells.开发新型荧光组氨酸 H 受体拮抗剂,以研究活细胞中的配体结合动力学。
Sci Rep. 2018 Jan 25;8(1):1572. doi: 10.1038/s41598-018-19714-2.
9
Real-time analysis of the binding of fluorescent VEGFa to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes.活细胞中荧光VEGFa与VEGFR2结合的实时分析:受体酪氨酸激酶抑制剂的作用及内化激动剂-受体复合物的命运
Biochem Pharmacol. 2017 Jul 15;136:62-75. doi: 10.1016/j.bcp.2017.04.006. Epub 2017 Apr 7.
10
Use of a new proximity assay (NanoBRET) to investigate the ligand-binding characteristics of three fluorescent ligands to the human -adrenoceptor expressed in HEK-293 cells.使用一种新的邻近分析法(NanoBRET)来研究三种荧光配体与人肾上腺素能受体(在HEK-293细胞中表达)的配体结合特性。
Pharmacol Res Perspect. 2016 Aug 8;4(5):e00250. doi: 10.1002/prp2.250. eCollection 2016 Oct.
Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization.
腺苷A(1)和A(3)受体的变构相互作用:小分子作用及受体二聚化作用的新见解
Br J Pharmacol. 2014 Mar;171(5):1102-13. doi: 10.1111/bph.12345.
4
Adenosine-A3 receptors in neutrophil microdomains promote the formation of bacteria-tethering cytonemes.中性粒细胞微域中的腺苷 A3 受体促进了细菌黏附丝状伪足的形成。
EMBO Rep. 2013 Aug;14(8):726-32. doi: 10.1038/embor.2013.89. Epub 2013 Jul 2.
5
The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs.用于A类G蛋白偶联受体的不断发展的小分子荧光共轭工具箱。
Br J Pharmacol. 2014 Mar;171(5):1073-84. doi: 10.1111/bph.12265.
6
Molecular signatures of G-protein-coupled receptors.G 蛋白偶联受体的分子特征。
Nature. 2013 Feb 14;494(7436):185-94. doi: 10.1038/nature11896.
7
Structure-function of the G protein-coupled receptor superfamily.G 蛋白偶联受体超家族的结构与功能。
Annu Rev Pharmacol Toxicol. 2013;53:531-56. doi: 10.1146/annurev-pharmtox-032112-135923. Epub 2012 Nov 8.
8
Fragment screening at adenosine-A(3) receptors in living cells using a fluorescence-based binding assay.使用基于荧光的结合测定法在活细胞中对腺苷 - A(3) 受体进行片段筛选。
Chem Biol. 2012 Sep 21;19(9):1105-15. doi: 10.1016/j.chembiol.2012.07.014.
9
Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time.重结合:或者为什么药物在体内的作用时间可能比体外靶标停留时间预期的要长。
Expert Opin Drug Discov. 2010 Oct;5(10):927-41. doi: 10.1517/17460441.2010.512037. Epub 2010 Aug 17.
10
New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.核苷酸、腺苷及其受体调节趋化作用的新见解。
Purinergic Signal. 2012 Sep;8(3):587-98. doi: 10.1007/s11302-012-9311-x. Epub 2012 Apr 15.